linsidomine has been researched along with Reperfusion Injury in 14 studies
linsidomine: RN given refers to parent cpd; structure
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
Excerpt | Relevance | Reference |
---|---|---|
"Previous studies have suggested reductions in lung reperfusion injury with pentoxifylline, inositol polyanions, and the nitric oxide donor, SIN-1, but these agents have never been directly compared to ascertain which is superior." | 7.70 | Modulation of reperfusion injury after single lung transplantation by pentoxifylline, inositol polyanions, and sin-1. ( Clark, SC; Dark, JH; Flecknell, PA; Roughan, J; Sudarshan, C, 1999) |
" The aim of our research was to compare molsidomine, SIN-1, SIN-1A, and lidocaine influence on arrhythmias and hemodynamic parameters in 2 experimental models in rats." | 3.85 | New approach to molsidomine active metabolites coming from the results of 2 models of experimental cardiology. ( Krzemiński, TF; Mitręga, KA; Porc, M; Żorniak, M, 2017) |
"Previous studies have suggested reductions in lung reperfusion injury with pentoxifylline, inositol polyanions, and the nitric oxide donor, SIN-1, but these agents have never been directly compared to ascertain which is superior." | 3.70 | Modulation of reperfusion injury after single lung transplantation by pentoxifylline, inositol polyanions, and sin-1. ( Clark, SC; Dark, JH; Flecknell, PA; Roughan, J; Sudarshan, C, 1999) |
"Ischemia-reperfusion injury causes tissue damage that leads to a decrease in bioavailability of nitric oxide." | 1.31 | The effects of the nitric oxide donor SIN-1 on ischemia-reperfused cutaneous and myocutaneous flaps. ( Kerrigan, CL; Khiabani, KT, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (50.00) | 18.2507 |
2000's | 6 (42.86) | 29.6817 |
2010's | 1 (7.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Żorniak, M | 1 |
Mitręga, KA | 1 |
Porc, M | 1 |
Krzemiński, TF | 1 |
Yokozawa, T | 1 |
Rhyu, DY | 1 |
Cho, EJ | 1 |
Aoyagi, K | 1 |
Nielsen, VG | 1 |
Crow, JP | 1 |
Savoye, G | 1 |
Tamion, F | 1 |
Richard, V | 1 |
Varin, R | 1 |
Thuillez, C | 1 |
Kaundal, RK | 1 |
Shah, KK | 1 |
Sharma, SS | 1 |
Payne, D | 1 |
Kubes, P | 1 |
Lee, JJ | 1 |
Olmos, L | 1 |
Vanhoutte, PM | 1 |
Huang, YC | 1 |
Fisher, PW | 1 |
Nozik-Grayck, E | 1 |
Piantadosi, CA | 1 |
Yokoyama, I | 1 |
Hayashi, S | 1 |
Kobayashi, T | 1 |
Negita, M | 1 |
Namii, Y | 1 |
Katayama, A | 1 |
Nagasaka, T | 1 |
Koike, C | 1 |
Tachi, Y | 1 |
Hayakawa, A | 1 |
Tajiri, H | 1 |
Takagi, H | 1 |
Johnson, D | 2 |
Freischlag, JA | 2 |
Lesniak, R | 2 |
Kelly, H | 2 |
Mudaliar, JH | 2 |
Cambria, RA | 2 |
Seabrook, MD | 2 |
Towne, JB | 2 |
Clark, SC | 1 |
Sudarshan, C | 1 |
Roughan, J | 1 |
Flecknell, PA | 1 |
Dark, JH | 1 |
Lepore, DA | 1 |
Hurley, JV | 1 |
Stewart, AG | 1 |
Morrison, WA | 1 |
Anderson, RL | 1 |
Khiabani, KT | 1 |
Kerrigan, CL | 1 |
14 other studies available for linsidomine and Reperfusion Injury
Article | Year |
---|---|
New approach to molsidomine active metabolites coming from the results of 2 models of experimental cardiology.
Topics: Animals; Anti-Asthmatic Agents; Arrhythmias, Cardiac; Creatine Kinase; Disease Models, Animal; Hemod | 2017 |
Protective activity of (-)-epicatechin 3-O-gallate against peroxynitrite-mediated renal damage.
Topics: Animals; Antioxidants; Caspases; Catechin; Cell Cycle; Cell Line; Cell Survival; DNA Fragmentation; | 2003 |
Peroxynitrite decreases rabbit tissue factor activity in vitro.
Topics: Animals; Blood Coagulation; Brain Chemistry; Humans; In Vitro Techniques; Molsidomine; Nitric Oxide | 2004 |
Hemorrhagic shock resuscitation affects early and selective mesenteric artery endothelial function through a free radical-dependent mechanism.
Topics: Acetylcholine; Animals; Blood Pressure; Dose-Response Relationship, Drug; Endothelium, Vascular; Fre | 2005 |
Neuroprotective effects of NU1025, a PARP inhibitor in cerebral ischemia are mediated through reduction in NAD depletion and DNA fragmentation.
Topics: Animals; Apoptosis; Brain; Brain Ischemia; Cell Survival; Disease Models, Animal; DNA Fragmentation; | 2006 |
Nitric oxide donors reduce the rise in reperfusion-induced intestinal mucosal permeability.
Topics: Animals; Cats; Cyclic GMP; Intestinal Mucosa; Intestines; Ischemia; Molsidomine; Nitric Oxide; Nitro | 1993 |
Recovery of endothelium-dependent relaxations four weeks after ischemia and progressive reperfusion in canine coronary arteries.
Topics: Acetylcholine; Adenosine Diphosphate; Animals; Arteries; Bradykinin; Coronary Vessels; Dogs; Dose-Re | 1996 |
Hypoxia compared with normoxia alters the effects of nitric oxide in ischemia-reperfusion lung injury.
Topics: Animals; Arginine; Blood Pressure; Hypoxia; In Vitro Techniques; Lung; Male; Microcirculation; Molsi | 1997 |
Hepatocyte apoptosis and cytosolic calcium dynamics in ischemic injury.
Topics: Animals; Apoptosis; Cells, Cultured; DNA Fragmentation; Ischemia; Liver; Mice; Mice, Inbred BALB C; | 1997 |
Endothelial damage due to ischemia and reperfusion is prevented with SIN-1.
Topics: Animals; Endothelium, Vascular; Male; Molsidomine; Rabbits; Reperfusion Injury; Vasodilation; Vasodi | 1998 |
Endothelial damage due to ischemia and reperfusion is prevented with SIN-1.
Topics: Animals; Endothelium, Vascular; Hindlimb; Male; Molsidomine; Rabbits; Reperfusion Injury; Sodium-Pot | 1998 |
Modulation of reperfusion injury after single lung transplantation by pentoxifylline, inositol polyanions, and sin-1.
Topics: Animals; Blood Platelets; Female; Free Radical Scavengers; Lung; Lung Transplantation; Malondialdehy | 1999 |
Prior heat stress improves survival of ischemic-reperfused skeletal muscle in vivo.
Topics: Animals; Cell Survival; Cells, Cultured; Clone Cells; Heat-Shock Response; Hot Temperature; HSP70 He | 2000 |
The effects of the nitric oxide donor SIN-1 on ischemia-reperfused cutaneous and myocutaneous flaps.
Topics: Animals; Cell Survival; Female; Molsidomine; Neutrophils; Nitric Oxide Donors; Reperfusion Injury; S | 2002 |